Skip to main content
ACAD logo

ACAD · Acadia Pharmaceuticals Inc · Analyst Estimates

Track ACAD — free
$20.15 -0.07 (-0.35%) At close · Sep 30
Market Cap
$3.44B
Shares
172.31M
Volume · Sep 30 3.13M Avg daily vol (3M) 1.77M

Analyst Estimates

Compare analyst forecasts for Acadia Pharmaceuticals Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-26 07:09 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.5
0.59933
0.72
—
0.59933
0.36668
0.59933
0.38224
— — — —
EPS
analysts
Publication date not stated
— — —
14
— — — —
0
0
13
2
Revenue
USD
Publication date not stated
1255053370
1273201370
1309088890
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
19
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.22
0.88853
1.87
—
0.88996
0.8546
0.88996
0.88271
— — — —
EPS
analysts
Publication date not stated
— — —
14
— — — —
5
0
8
2
Revenue
USD
Publication date not stated
1333864360
1433055080
1580000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
19
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.11
0.18536
0.33
—
0.18536
0.12974
0.18536
0.12605
— — — —
EPS
analysts
Publication date not stated
— — —
14
— — — —
0
0
10
1
Revenue
USD
Publication date not stated
325000000
331775970
341880000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
17
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.14
0.21469
0.26
—
0.21469
0.17207
0.21469
0.1679
— — — —
EPS
analysts
Publication date not stated
— — —
14
— — — —
2
0
9
1
Revenue
USD
Publication date not stated
350600000
363214700
375000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
17
— — — — — — — —
Key facts CIK 1070494 CUSIP 004225108 13F (30d) 14 filings 11 filers Visit website Investor relations